Free Trial
→ Every Starlink dish pays this stock (From Behind the Markets) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
B2Gold Corp stock logo
BTG
B2Gold
$4.91
-1.0%		$5.20
$3.57
▼
$6.28
$6.53B0.6425.83 million shs22.09 million shs
Ironwood Pharmaceuticals, Inc. stock logo
IRWD
Ironwood Pharmaceuticals
$4.83
-0.4%		$3.97
$2.95
▼
$5.78
$802.92M0.252.39 million shs2.81 million shs
Transocean Ltd. stock logo
RIG
Transocean
$5.53
+3.9%		$5.68
$3.68
▼
$7.66
$5.94B1.4444.89 million shs30.14 million shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
B2Gold Corp stock logo
BTG
B2Gold
-1.01%-9.07%-1.60%-4.47%+17.46%
Ironwood Pharmaceuticals, Inc. stock logo
IRWD
Ironwood Pharmaceuticals
-0.41%+10.02%+34.17%+12.06%+55.31%
Transocean Ltd. stock logo
RIG
Transocean
+3.76%+5.34%-0.90%-4.16%+34.26%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
B2Gold Corp stock logo
BTG
B2Gold
$4.91
-1.0%		$5.20
$3.57
▼
$6.28
$6.53B0.6425.83 million shs22.09 million shs
Ironwood Pharmaceuticals, Inc. stock logo
IRWD
Ironwood Pharmaceuticals
$4.83
-0.4%		$3.97
$2.95
▼
$5.78
$802.92M0.252.39 million shs2.81 million shs
Transocean Ltd. stock logo
RIG
Transocean
$5.53
+3.9%		$5.68
$3.68
▼
$7.66
$5.94B1.4444.89 million shs30.14 million shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
B2Gold Corp stock logo
BTG
B2Gold
-1.01%-9.07%-1.60%-4.47%+17.46%
Ironwood Pharmaceuticals, Inc. stock logo
IRWD
Ironwood Pharmaceuticals
-0.41%+10.02%+34.17%+12.06%+55.31%
Transocean Ltd. stock logo
RIG
Transocean
+3.76%+5.34%-0.90%-4.16%+34.26%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
B2Gold Corp stock logo
BTG
B2Gold
3.00
Buy$6.8138.75% Upside
Ironwood Pharmaceuticals, Inc. stock logo
IRWD
Ironwood Pharmaceuticals
2.57
Moderate Buy$6.2329.05% Upside
Transocean Ltd. stock logo
RIG
Transocean
2.17
Hold$6.6119.59% Upside

Current Analyst Ratings Breakdown

Latest RIG, BTG, and IRWD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/9/2026
Transocean Ltd. stock logo
RIG
Transocean
Morgan Stanley logo
Morgan Stanley
Subscribe to MarketBeat All Access to unlock brokerage rankings
Lower Price TargetEqual Weight$7.00 ➝ $6.50
11/6/2026
Transocean Ltd. stock logo
RIG
Transocean
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access to unlock brokerage rankings
DowngradeStrong-Buy ➝ Hold
10/15/2026
Transocean Ltd. stock logo
RIG
Transocean
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
Reiterated RatingSell (D-)
10/8/2026
Ironwood Pharmaceuticals, Inc. stock logo
IRWD
Ironwood Pharmaceuticals
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
UpgradeHold (C) ➝ Hold (C+)
10/5/2026
Transocean Ltd. stock logo
RIG
Transocean
Zacks Research logo
Zacks Research
Subscribe to MarketBeat All Access to unlock brokerage rankings
UpgradeHold ➝ Strong-Buy
9/25/2026
Ironwood Pharmaceuticals, Inc. stock logo
IRWD
Ironwood Pharmaceuticals
Jefferies Financial Group Inc. logo
Jefferies Financial Group
Subscribe to MarketBeat All Access to unlock brokerage rankings
UpgradeHold
9/16/2026
B2Gold Corp stock logo
BTG
B2Gold
Royal Bank Of Canada logo
Royal Bank Of Canada
Subscribe to MarketBeat All Access to unlock brokerage rankings
Boost Price TargetSector Perform$5.00 ➝ $6.25
9/4/2026
Ironwood Pharmaceuticals, Inc. stock logo
IRWD
Ironwood Pharmaceuticals
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
DowngradeHold (C+) ➝ Hold (C)
9/4/2026
B2Gold Corp stock logo
BTG
B2Gold
Raymond James Financial, Inc. logo
Raymond James Financial
Subscribe to MarketBeat All Access to unlock brokerage rankings
Boost Price TargetOutperform$7.25 ➝ $7.50
8/21/2026
Ironwood Pharmaceuticals, Inc. stock logo
IRWD
Ironwood Pharmaceuticals
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access to unlock brokerage rankings
UpgradeHold (C-) ➝ Hold (C+)
(Data available from 11/14/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
B2Gold Corp stock logo
BTG
B2Gold
$3.06B2.11$0.78 per share6.32$3.35 per share1.47
Ironwood Pharmaceuticals, Inc. stock logo
IRWD
Ironwood Pharmaceuticals
$296.15M2.70$0.26 per share18.84($0.59) per share-8.19
Transocean Ltd. stock logo
RIG
Transocean
$4.03B1.53$0.70 per share7.88$7.57 per share0.73
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
B2Gold Corp stock logo
BTG
B2Gold
$401.91M-$0.0310.555.850.2631.33%16.00%10.59%N/A
Ironwood Pharmaceuticals, Inc. stock logo
IRWD
Ironwood Pharmaceuticals
$24.02M$0.905.39N/AN/A37.38%-81.40%42.69%N/A
Transocean Ltd. stock logo
RIG
Transocean
-$2.92B$0.1439.4620.463.637.25%1.84%1.00%N/A

Latest RIG, BTG, and IRWD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/5/2026Q3 2026
Ironwood Pharmaceuticals, Inc. stock logo
IRWD
Ironwood Pharmaceuticals
$0.3233$0.36+$0.0367$0.36$119.99 million$133.04 million
11/4/2026Q3 2026
B2Gold Corp stock logo
BTG
B2Gold
$0.09$0.14+$0.05$0.28$822.76 million$836.00 million
11/2/2026Q3 2026
Transocean Ltd. stock logo
RIG
Transocean
$0.0223$0.02-$0.0023$0.02$943.99 million$937.00 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
B2Gold Corp stock logo
BTG
B2Gold
$0.081.63%N/AN/A N/A
Ironwood Pharmaceuticals, Inc. stock logo
IRWD
Ironwood Pharmaceuticals
N/AN/AN/AN/AN/A
Transocean Ltd. stock logo
RIG
Transocean
$0.6010.86%N/A428.57%N/A

Latest RIG, BTG, and IRWD Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
11/4/2026
B2Gold Corp stock logo
BTG
B2Gold
quarterly$0.021.51%12/2/202612/2/202612/15/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
B2Gold Corp stock logo
BTG
B2Gold
0.12
1.77
0.66
Ironwood Pharmaceuticals, Inc. stock logo
IRWD
Ironwood Pharmaceuticals
N/A
6.51
6.06
Transocean Ltd. stock logo
RIG
Transocean
0.54
1.53
1.24

Institutional Ownership

CompanyInstitutional Ownership
B2Gold Corp stock logo
BTG
B2Gold
61.40%
Ironwood Pharmaceuticals, Inc. stock logo
IRWD
Ironwood Pharmaceuticals
N/A
Transocean Ltd. stock logo
RIG
Transocean
67.73%

Insider Ownership

CompanyInsider Ownership
B2Gold Corp stock logo
BTG
B2Gold
1.18%
Ironwood Pharmaceuticals, Inc. stock logo
IRWD
Ironwood Pharmaceuticals
9.30%
Transocean Ltd. stock logo
RIG
Transocean
9.70%
CompanyEmployeesShares OutstandingFree FloatOptionable
B2Gold Corp stock logo
BTG
B2Gold
6,3271.32 billion1.30 billionNot Optionable
Ironwood Pharmaceuticals, Inc. stock logo
IRWD
Ironwood Pharmaceuticals
100165.55 million149.87 millionOptionable
Transocean Ltd. stock logo
RIG
Transocean
5,6001.12 billion1.01 billionOptionable

Recent News About These Companies

Keybank National Association OH Makes New $67.43 Million Investment in Transocean Ltd. $RIG
November 11 at 5:55 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-keybank-national-association-oh-makes-new-6743-million-investment-in-transocean-ltd-rig-2026-11-11/
Traders Purchase High Volume of Transocean Call Options (NYSE:RIG)
November 10, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/options-traders-purchase-high-volume-of-transocean-call-options-nyse-rig-2026-11-10/
3,778,762 Shares in Transocean Ltd. $RIG Acquired by Penn Capital Management Company LLC
November 10, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-3778762-shares-in-transocean-ltd-rig-acquired-by-penn-capital-management-company-llc-2026-11-10/
Transocean (NYSE:RIG) Stock Price Target Cut by Morgan Stanley
November 9, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-transocean-nyse-rig-stock-price-target-cut-by-morgan-stanley-2026-11-09/
Morgan Stanley Adjusts Transocean Price Target to $6.50 From $7
November 9, 2026  |  marketscreener.comM
Transocean (NYSE:RIG) Downgraded by Wall Street Zen to Sell
November 7, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31183019
Transocean (NYSE:RIG) Stock Rating Lowered by Wall Street Zen
November 7, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/analyst-transocean-nyse-rig-stock-rating-lowered-by-wall-street-zen-2026-11-07/
Transocean (NYSE:RIG) Share Price Crosses Below 200-Day Moving Average - Should You Sell?
November 5, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/price-transocean-nyse-rig-share-price-crosses-below-200-day-moving-average-should-you-sell-2026-11-05/
Transocean (RIG) Dropped, So What Is Behind Its Latest Update?
November 4, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/transocean-rig-dropped-behind-latest-161652134.html
Transocean (NYSE:RIG) Releases Earnings Results, Hits Expectations
November 4, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/earnings-transocean-nyse-rig-releases-earnings-results-hits-expectations-2026-11-04/
Transocean's Plunge Offers Upside As Its Big Merger Nears
November 4, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4961965-transocean-stock-plunge-offers-upside-big-merger-nears
Is Transocean (RIG) Entering A New Growth Phase After Its Strong Quarter?
November 4, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/transocean-rig-entering-growth-phase-070927389.html
Transocean (RIG) Stock Looks Fairly Priced Against Future Cash Flow
November 4, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/transocean-rig-stock-looks-fairly-091251523.html
Transocean Q3 Earnings Call Highlights
November 4, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/transcript-transocean-q3-earnings-call-highlights-2026-11-04/
Transocean (RIG) Q3 2026 Earnings Call Transcript
November 3, 2026  |  fool.comhttps://www.fool.com/earnings/call-transcripts/2026/11/03/transocean-rig-q3-2026-earnings-call-transcript/
Transocean secures contracts worth $2B in backlog in latest fleet status report
November 3, 2026  |  seekingalpha.comhttps://seekingalpha.com/news/4663717-transocean-secures-contracts-worth-2b-in-backlog-in-latest-fleet-status-report
RIG Q3 deep dive: Valaris acquisition and tight rig markets shape Transocean’s outlook
November 3, 2026  |  msn.comhttps://www.msn.com/en-us/news/other/rig-q3-deep-dive-valaris-acquisition-and-tight-rig-markets-shape-transocean-s-outlook/ar-AA2gG3lI
Transocean: Q3 Earnings Snapshot
November 3, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/transocean-q3-earnings-snapshot-043632394.html
Transocean Swings To Profit In Q3
November 2, 2026  |  rttnews.comhttps://www.rttnews.com/3707391/transocean-swings-to-profit-in-q3.aspx
Earnings Flash (RIG) Transocean Posts Q3 Adjusted EPS $0, vs. FactSet Est of $0.02
November 2, 2026  |  marketscreener.comM
Transocean Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026
November 2, 2026  |  marketscreener.comM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Comfort Systems USA logo over rooftop HVAC units and piping at a data center facility during sunset.
Comfort Systems Earnings: AI Slowdown or More Growth Ahead?
By Dan Schmidt | October 26, 2026
Coca-Cola bottle, Monster Energy can, and Dr Pepper can displayed against a city skyline with an upward green stock chart arrow.
Consumer Staples Are Up 12% This Year—These 3 Beverage Stocks Are Leading the Way
By Dan Schmidt | October 25, 2026
A nurse in blue scrubs with a stethoscope stands in a hospital hallway as staff attend to patients nearby.
Women Drive the Job Market—These 3 Stocks Are Following Them
By Chris Markoch | October 19, 2026
Rare Earth Stocks Face a 2027 Defense Deadline Neither Party Plans to Move
America’s Rare Earth Clock Is Running Out, But the Bottleneck Isn’t Where You Think
By Bridget Bennett | November 9, 2026
Split image showing refrigerated Dr Pepper and Ghost Energy cans, plus a Keurig coffee maker with Peet's and Green Mountain K-Cup pods.
Keurig Dr Pepper's Beverage Growth Raises a Tough Question About Its Coffee Split
By Chris Markoch | November 5, 2026
B2Gold stock logo

B2Gold NYSEAMERICAN:BTG

$4.91 -0.05 (-1.01%)
Closing price 11/13/2026 04:10 PM Eastern
Extended Trading
$4.92 +0.00 (+0.10%)
As of 11/13/2026 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

B2Gold Corp. operates as a gold producer company. It operates the Fekola Mine in Mali, the Masbate Mine in the Philippines, and the Otjikoto Mine in Namibia. The company also has an 100% interest in the Gramalote gold project in Colombia; 24% interest in the Calibre Mining Corp.; and approximately 19% interest in BeMetals Corp. In addition, it has a portfolio of other evaluation and exploration assets in Mali and Finland. The company was incorporated in 2006 and is headquartered in Vancouver, Canada.

Ironwood Pharmaceuticals stock logo

Ironwood Pharmaceuticals NASDAQ:IRWD

$4.83 -0.02 (-0.41%)
Closing price 11/13/2026 04:00 PM Eastern
Extended Trading
$4.82 -0.01 (-0.21%)
As of 11/13/2026 07:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C (GC-C) agonist for the treatment of adults suffering from irritable bowel syndrome with constipation or chronic idiopathic constipation under the LINZESS name in the United States, Mexico, Japan, Saudi Arabia, and China, as well as under the CONSTELLA name in the Canada and European countries. The company is also developing IW-3300, a GC-C agonist for the treatment of visceral pain conditions, including interstitial cystitis/bladder pain syndrome and endometriosis; Apraglutide, a next-generation, long-acting synthetic peptide analog of glucagon-like peptide-2, as a differentiated therapeutic for rare diseases, including short bowel syndrome dependent on parenteral support and acute graft versus host disease; and CNP-104, an immune nanoparticle for the treatment of primary biliary cholangitis. The company has strategic partnerships with AbbVie Inc., AstraZeneca AB, and Astellas Pharma Inc. for the development and commercialization of linaclotide. The company was formerly known as Microbia, Inc. and changed its name to Ironwood Pharmaceuticals, Inc. in April 2008. Ironwood Pharmaceuticals, Inc. was incorporated in 1998 and is headquartered in Boston, Massachusetts.

Transocean stock logo

Transocean NYSE:RIG

$5.52 +0.21 (+3.85%)
Closing price 11/13/2026 03:59 PM Eastern
Extended Trading
$5.55 +0.02 (+0.40%)
As of 11/13/2026 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Transocean Ltd., together with its subsidiaries, provides offshore contract drilling services for oil and gas wells worldwide. It contracts mobile offshore drilling rigs, related equipment, and work crews to drill oil and gas wells. The company operates a fleet of mobile offshore drilling units, consisting of ultra-deepwater floaters and harsh environment floaters. It serves integrated energy companies, government-owned or government-controlled energy companies, and other independent energy companies. The company was founded in 1926 and is based in Steinhausen, Switzerland.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas